Selected article for: "endosomal receptor and GP binding"

Author: Brauburger, Kristina; Hume, Adam J.; Mühlberger, Elke; Olejnik, Judith
Title: Forty-Five Years of Marburg Virus Research
  • Document date: 2012_10_1
  • ID: 0hlj6r10_74
    Snippet: The current model of EBOV and MARV fusion is that GP 1 cleavage by endosomal proteases removes heavily glycosylated domains, exposing the receptor binding domain on GP 1 and enabling binding to NPC1 [95] . The membrane-bound fusogenic GP 2 undergoes a low pH-dependent rearrangement to an extended conformation resulting in the fusion of virion and endo-lysosomal membranes [96] . In support of the pH-dependence of GP-mediated fusion, pre-treatment .....
    Document: The current model of EBOV and MARV fusion is that GP 1 cleavage by endosomal proteases removes heavily glycosylated domains, exposing the receptor binding domain on GP 1 and enabling binding to NPC1 [95] . The membrane-bound fusogenic GP 2 undergoes a low pH-dependent rearrangement to an extended conformation resulting in the fusion of virion and endo-lysosomal membranes [96] . In support of the pH-dependence of GP-mediated fusion, pre-treatment of cells with ammonium chloride prevented entry of a MARV GP-pseudotyped virus [183] . A recent report with live MARV showed that ammonium chloride inhibited entry and replication, but that Bafilomycin A 1 , which specifically inhibits vacuolar-type H(+) ATPase and prevents re-acidification of vesicles of the central vacuolar system, surprisingly had no effect [172] . Following viral fusion with the endosomal membrane, the nucleocapsid is released into the cytoplasm (Figure 7 ).

    Search related documents:
    Co phrase search for related documents
    • ammonium chloride and endosomal protease: 1
    • cytoplasm release and endosomal membrane: 1, 2, 3, 4, 5
    • cytoplasm release and endosomal membrane viral fusion: 1, 2